Indication

Smoking Cessation

15 clinical trials

17 products

1 drug

Clinical trial
A Multicenter, Open-Label Study Assessing Long-Term Exposure With Cytisinicline 3 mg TID
Status: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
Status: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
Oral Cannabidiol for Tobacco Cessation
Status: Recruiting, Estimated PCD: 2024-11-01
Product
Placebo
Product
Nicotine
Clinical trial
Smoking Cessation Pilot Program on 9 South
Status: Withdrawn, Estimated PCD: 2023-04-01
Clinical trial
Emergency Department Based Management of Tobacco Use Disorder
Status: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Status: Completed, Estimated PCD: 2023-06-14
Product
Isradipine
Product
Bupropion